Is folic acid supplementation really necessary in preterm infants ≤ 32 weeks of gestation?

Mehmet Yekta Oncel1, Erhan Calisici, Ramazan Ozdemir

  • 1*Division of Neonatology, Zekai Tahir Burak Maternity Teaching Hospital, Ankara †Department of Pediatrics, Division of Neonatology, Inönü University School of Medicine, Malatya ‡Department of Pediatrics, Division of Neonatology, Ankara University School of Medicine §Department of Biostatistics, Hacettepe University, Faculty of Medicine.

Insights

Preterm infants fed fortified diets or preterm formula had adequate folate levels. Human breast milk alone may pose a risk for folate deficiency, particularly if mothers smoke or don't supplement folic acid.

Area of Science:

  • Neonatology
  • Nutritional Science
  • Pediatric Nutrition

Background:

  • Preterm infants are at risk for nutritional deficiencies.
  • Folate is crucial for infant development.
  • Feeding modalities can impact nutrient levels in preterm infants.

Purpose of the Study:

  • To determine folate deficiency in hospitalized preterm infants.
  • To assess the impact of feeding methods on serum folate levels.

Main Methods:

  • 162 preterm infants (≤32 weeks gestation) were studied.
  • Serum folate levels were measured at 14, 28 days, and 36 weeks postconception.
  • Infants were fed human breast milk (HBM), fortified HBM (fHBM), or preterm formula (PF).

Main Results:

  • No folate deficiency was observed in any group.
  • fHBM and PF groups showed higher serum folate levels at 36 weeks compared to HBM alone.
  • Maternal folic acid supplementation and smoking significantly affected infant folate levels early postnatally.

Conclusions:

  • Parenteral nutrition with adequate folic acid prevents deficiency in preterm infants.
  • Exclusive HBM or low-folate PF may increase deficiency risk, especially with maternal smoking or lack of prenatal folic acid supplementation.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...